MX2018006823A - Una composicion para mejorar la memoria, capacidad de aprendizaje y capacidad cognitiva. - Google Patents
Una composicion para mejorar la memoria, capacidad de aprendizaje y capacidad cognitiva.Info
- Publication number
- MX2018006823A MX2018006823A MX2018006823A MX2018006823A MX2018006823A MX 2018006823 A MX2018006823 A MX 2018006823A MX 2018006823 A MX2018006823 A MX 2018006823A MX 2018006823 A MX2018006823 A MX 2018006823A MX 2018006823 A MX2018006823 A MX 2018006823A
- Authority
- MX
- Mexico
- Prior art keywords
- cognition
- composition
- improving memory
- learning ability
- peptide
- Prior art date
Links
- 230000019771 cognition Effects 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 5
- 150000001413 amino acids Chemical class 0.000 abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1021—Tetrapeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Psychology (AREA)
Abstract
Se proporciona una composición para mejorar la memoria, capacidad de aprendizaje y capacidad cognitiva. Se ha confirmado que un péptido que tiene una región C-terminal terminada a GAG tuvo un efecto para mejorar la memoria. Para que el péptido tenga el efecto, se ha confirmado que el péptido debería ser un péptido cuya longitud conste de al menos 4 aminoácidos. Además, se ha confirmado que un péptido cuya longitud del péptido que tiene la región C-terminal terminada en GAG consiste en 5 a 9 aminoácidos tiene el mismo efecto. Como resultado, el péptido de la presente invención puede usarse como la composición para mejorar la memoria, la capacidad de aprendizaje y la capacidad cognitiva.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150183011A KR101706296B1 (ko) | 2015-12-21 | 2015-12-21 | 기억력, 학습력, 인지력 향상용 조성물 |
KR1020160026600A KR101844481B1 (ko) | 2016-03-04 | 2016-03-04 | 기억력 향상 효과를 가지는 펩타이드 |
PCT/KR2016/004650 WO2017111215A1 (ko) | 2015-12-21 | 2016-05-03 | 기억력, 학습력, 인지력 향상용 조성물 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018006823A true MX2018006823A (es) | 2018-11-29 |
Family
ID=59090692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018006823A MX2018006823A (es) | 2015-12-21 | 2016-05-03 | Una composicion para mejorar la memoria, capacidad de aprendizaje y capacidad cognitiva. |
Country Status (15)
Country | Link |
---|---|
US (4) | US20180201645A1 (es) |
EP (1) | EP3255055B1 (es) |
JP (1) | JP6463499B2 (es) |
CN (2) | CN107406482A (es) |
AU (2) | AU2016376059B2 (es) |
BR (1) | BR112018012527A2 (es) |
CA (1) | CA2965840C (es) |
MX (1) | MX2018006823A (es) |
MY (1) | MY197348A (es) |
PH (1) | PH12017550079A1 (es) |
RU (1) | RU2694064C1 (es) |
SA (1) | SA518391710B1 (es) |
SG (1) | SG11201804902UA (es) |
TR (1) | TR201807610T1 (es) |
WO (1) | WO2017111215A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2743293C1 (ru) * | 2020-07-06 | 2021-02-16 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Применение пептида Gly-His-Lys-Val-Glu-Pro для повышения обучаемости и улучшения памяти. |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5243038A (en) * | 1986-11-04 | 1993-09-07 | Protein Polymer Technologies, Inc. | Construction of synthetic DNA and its use in large polypeptide synthesis |
ATE233273T1 (de) | 1986-11-04 | 2003-03-15 | Protein Polymer Tech Inc | Herstellung synthetischer dns und deren verwendung bei der synthese grosser polypeptide |
US5606019A (en) * | 1987-10-29 | 1997-02-25 | Protien Polymer Technologies, Inc. | Synthetic protein as implantables |
SG47030A1 (en) * | 1994-01-03 | 1998-03-20 | Genentech Inc | Thrombopoietin |
US6069129A (en) * | 1998-03-13 | 2000-05-30 | Mrs, Llc | Elastin derived composition and method of using same |
JP2002522504A (ja) * | 1998-08-13 | 2002-07-23 | ジー・ディー・サール・アンド・カンパニー | 多価avb3および転移関連レセプター・リガンド |
US6608242B1 (en) * | 2000-05-25 | 2003-08-19 | E. I. Du Pont De Nemours And Company | Production of silk-like proteins in plants |
WO2002010430A2 (en) * | 2000-07-31 | 2002-02-07 | Amidut Ltd. | Detecting anti-viral drug candidates and resistance |
BR0207476A (pt) * | 2001-02-22 | 2006-01-24 | Zealand Pharma As | Uso de um composto,e, composição farmacêutica |
US7056889B2 (en) * | 2002-12-16 | 2006-06-06 | Kimberly-Clark, Worldwide, Inc. | Compounds that bind P2Y2 or P2Y1 receptors |
CN1532281A (zh) * | 2003-03-21 | 2004-09-29 | 吉林大学第一医院 | 癌胚抗原基因片段的重组及基因疫苗 |
EP1633382A4 (en) * | 2003-05-14 | 2009-08-05 | Dow Corning | REPEAT SEQUENCE PROTEIN-POLYMER-ACTIVE CONJUGATE, METHOD AND USES |
US7148192B2 (en) | 2004-01-29 | 2006-12-12 | Ebwe Pharma Ges. M.H. Nfg.Kg | Neuroprotective dietary supplement |
KR20050082389A (ko) * | 2004-02-18 | 2005-08-23 | 메덱스젠 주식회사 | 직렬 연쇄체를 갖는 면역접합체를 포함하는 장기이식합병증 치료용 약제학적 조성물 |
KR100494358B1 (ko) * | 2004-07-30 | 2005-06-10 | 주식회사 바이오그랜드 | 두뇌 또는 인지 기능 증진용 조성물 |
KR20070000892A (ko) * | 2005-06-28 | 2007-01-03 | 하성원 | 누에실크 피브로인의 재생방법 |
WO2007019860A2 (en) * | 2005-08-16 | 2007-02-22 | Copenhagen University | Gdnf derived peptides |
CA2628843A1 (en) * | 2005-11-07 | 2007-05-10 | Copenhagen University | Neurotrophin-derived peptide sequences |
WO2007065437A2 (en) * | 2005-12-06 | 2007-06-14 | P2-Science Aps | Modulation of the p2y2 receptor pathway |
WO2007124593A1 (en) * | 2006-05-02 | 2007-11-08 | Universite Laval | Branched peptide amplification and uses thereof |
KR100864380B1 (ko) * | 2006-10-17 | 2008-10-21 | 주식회사 브레인가드 | 두뇌기능 향상과 뇌신경계 질환 예방 또는 치료용 펩타이드 |
WO2010054319A2 (en) * | 2008-11-10 | 2010-05-14 | Codexis, Inc. | Penicillin-g acylases |
AU2010289692A1 (en) * | 2009-09-02 | 2012-04-19 | Kansas State University Research Foundation | MRI and optical assays for proteases |
EP2507255A1 (en) * | 2009-12-01 | 2012-10-10 | Universita' Degli Studi Di Modena E Reggio Emilia | Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer |
WO2011119484A1 (en) * | 2010-03-23 | 2011-09-29 | Iogenetics, Llc | Bioinformatic processes for determination of peptide binding |
ME02206B (me) | 2010-05-27 | 2016-02-20 | Centocor Ortho Biotech Inc | Receptor insulinu-sličnog faktora rasta 1 vezujući peptidi |
JP2012017287A (ja) * | 2010-07-07 | 2012-01-26 | Iwate Univ | 老齢性疾患治療薬 |
WO2012092718A1 (en) * | 2011-01-07 | 2012-07-12 | Nanjing University | Photo-responsive supramolecular hydrogels |
CN107782886A (zh) * | 2011-04-21 | 2018-03-09 | 生物梅里埃公司 | 使用质谱检测至少一种头孢菌素抗性机制的方法 |
WO2014145275A1 (en) * | 2013-03-15 | 2014-09-18 | The Uab Research Foundation | Methods for treatment of nephrotic syndrome and related conditions |
KR20150114916A (ko) * | 2014-04-02 | 2015-10-13 | 조아제약주식회사 | 기억력 증진 또는 집중력 향상 조성물 |
KR101430387B1 (ko) * | 2014-04-08 | 2014-08-13 | 강용구 | 실크 피브로인 유래 펩타이드, 및 이를 포함하는 기억력, 학습력, 인지력의 향상 또는 치매의 예방 또는 치료용 조성물 |
-
2016
- 2016-05-03 MY MYPI2018701947A patent/MY197348A/en unknown
- 2016-05-03 JP JP2017546737A patent/JP6463499B2/ja active Active
- 2016-05-03 CN CN201680013706.9A patent/CN107406482A/zh active Pending
- 2016-05-03 EP EP16879083.0A patent/EP3255055B1/en active Active
- 2016-05-03 TR TR2018/07610T patent/TR201807610T1/tr unknown
- 2016-05-03 AU AU2016376059A patent/AU2016376059B2/en active Active
- 2016-05-03 BR BR112018012527-0A patent/BR112018012527A2/pt active Search and Examination
- 2016-05-03 WO PCT/KR2016/004650 patent/WO2017111215A1/ko active Application Filing
- 2016-05-03 SG SG11201804902UA patent/SG11201804902UA/en unknown
- 2016-05-03 US US15/482,752 patent/US20180201645A1/en not_active Abandoned
- 2016-05-03 CN CN201910592808.6A patent/CN110279845B/zh active Active
- 2016-05-03 RU RU2018120516A patent/RU2694064C1/ru active
- 2016-05-03 CA CA2965840A patent/CA2965840C/en active Active
- 2016-05-03 MX MX2018006823A patent/MX2018006823A/es unknown
-
2017
- 2017-08-11 PH PH12017550079A patent/PH12017550079A1/en unknown
-
2018
- 2018-05-31 SA SA518391710A patent/SA518391710B1/ar unknown
- 2018-06-19 US US16/011,637 patent/US10435436B2/en active Active
- 2018-06-19 US US16/011,638 patent/US20180327452A1/en not_active Abandoned
-
2019
- 2019-01-23 AU AU2019200449A patent/AU2019200449A1/en not_active Abandoned
-
2022
- 2022-05-26 US US17/825,064 patent/US20220296673A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2016376059B2 (en) | 2019-02-14 |
CN110279845A (zh) | 2019-09-27 |
AU2019200449A1 (en) | 2019-02-07 |
TR201807610T1 (tr) | 2018-06-21 |
SA518391710B1 (ar) | 2022-11-09 |
RU2694064C1 (ru) | 2019-07-09 |
JP6463499B2 (ja) | 2019-02-06 |
AU2016376059A1 (en) | 2017-10-05 |
CA2965840A1 (en) | 2017-06-29 |
PH12017550079A1 (en) | 2018-02-12 |
CA2965840C (en) | 2021-11-30 |
CN107406482A (zh) | 2017-11-28 |
JP2018517394A (ja) | 2018-07-05 |
US20180201645A1 (en) | 2018-07-19 |
EP3255055B1 (en) | 2024-06-05 |
SG11201804902UA (en) | 2018-07-30 |
US10435436B2 (en) | 2019-10-08 |
WO2017111215A1 (ko) | 2017-06-29 |
BR112018012527A2 (pt) | 2018-12-11 |
US20180327451A1 (en) | 2018-11-15 |
US20180327452A1 (en) | 2018-11-15 |
EP3255055A1 (en) | 2017-12-13 |
EP3255055A4 (en) | 2018-04-18 |
CN110279845B (zh) | 2021-08-20 |
MY197348A (en) | 2023-06-14 |
US20220296673A1 (en) | 2022-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018501355A1 (en) | Rsv f protein mutants | |
PH12016502282A1 (en) | Improved immunoglobulin variable domains | |
MX2018005829A (es) | Composiciones para tratar el cabello. | |
TN2017000085A1 (en) | Polypeptide having a polyester degrading activity and uses thereof | |
BR112016024494A8 (pt) | análogo de peptídeo e seu uso | |
MX2017009595A (es) | Compuestos antisenescentes y usos de los mismos. | |
PH12018502714A1 (en) | Nicotine particles and compositions | |
AR120721A2 (es) | Péptidos y composiciones para el tratamiento de daño articular | |
SG11201706722YA (en) | Acid composition based on leonardite and amino acids | |
WO2015198240A3 (en) | Compositions and methods for long acting proteins | |
EP3360895A3 (en) | Preparation comprising factor viii and von willebrand factor peptides | |
BR112017006969A2 (pt) | peptídeo derivado de hsp70, composição farmacêutica para o tratamento ou a prevenção de câncer usando o mesmo, indutor de imunidade e método de produção de célula apresentadora de antígeno | |
NZ744289A (en) | Composition containing amino acids | |
MX2015009867A (es) | Mutantes del factor x. | |
MX2015002279A (es) | Peptido pntx(19) sintético, composición farmacéutica.y uso. | |
PH12017550079A1 (en) | Composition for improving memory, learning ability and cognition | |
MX2021001361A (es) | Composicion liquida de fibrinogeno humano. | |
MX2019009293A (es) | Compuestos, composiciones y usos de los mismos para la mejoria de trastornos oseos. | |
BR112018001207A2 (pt) | novo peptídeo e uso do mesmo | |
MX365952B (es) | Composiciones para la prevención y/o el tratamiento de patologías relacionadas con alfa-glucosidasa. | |
NZ727444A (en) | Prohemostatic proteins for the treatment of bleeding | |
MX2020006670A (es) | Composicion acuosa que comprende acido 2-(dimetil-1h-pirazol-1-il) succinico y amoniaco. | |
GR1008804B (el) | Συνθεσεις για ιατρικη χρηση οι οποιες περιλαμβανουν υαλουρονικο οξυ ή αλατα αυτου, αμινοξεα, βιταμινες, ανοργανα αλατα και αλλα συστατικα |